BONESUPPORT initiates buy-back for long-term incentive program
The board resolved to acquire up to 373,320 shares for SEK 100 million under LTI 2026.
See the latest news and media coverage for BONESUPPORT. We track all announcements, press releases, and industry mentions in real time, all in one place.
Scandinavian orthobiologics company
bonesupport.comLast updated
In short: BONESUPPORT reported record profits and robust U.S. growth through 2025 and 2026, while expanding its distribution and clinical evidence for CERAMENT.
The board resolved to acquire up to 373,320 shares for SEK 100 million under LTI 2026.
Net sales rose 14% to SEK 324.0 million. US growth was 16%. Adjusted operating result reached SEK 84.9 million.
The centre at Groote Schuur Hospital in Cape Town hosts educational sessions on FRI management, CERAMENT science, workshops, and live cases.
The report is available as PDF on the company's website. It was released on 2026-04-16.
Detailed price information for Bonesupport Holding Ab (BOEUF) from The Globe and Mail including charting and trades.
Quarterly Performance Highlights Bonesupport delivered exceptional financial results in Q2 2025, with net sales reaching SEK 284 million, representing a 29% increase compared to the...
Medtech company Bonesupport plans over a three-year period to conduct studies in the spinal area and arthroplasty for a total cost of 120...
Bonesupport's product Cerament used for treating bone injuries. Bonesupport now expects approximately 460,000 procedures within relevant orthopedic indications in the US, an increase...
Track BONESUPPORT and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to BONESUPPORT and other trending companies.